Cargando…
Persistence of immunity in children immunised with 13-valent pneumococcal conjugate vaccine and impact on nasopharyngeal carriage: a cross-sectional study
In 500 children aged ≤10 years after 13-valent pneumococcal conjugate vaccine (PCV)13 immunisation in different schedules, serotypes 19A-specific and 19F-specific immunoglobulin G (IgG) were predicted to persist above 0.35 µg/mL for ≥10 years in all groups, likely due to PCV13-induced memory with na...
Autores principales: | Janapatla, Rajendra Prasad, Hsu, Mei-Hua, Chen, Chyi-Liang, Wei, Sung-Hsi, Yu, Ming-Jia, Su, Lin-Hui, Lin, Tzou-Yien, Chiu, Cheng-Hsun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402562/ https://www.ncbi.nlm.nih.gov/pubmed/32444435 http://dx.doi.org/10.1136/thoraxjnl-2019-213878 |
Ejemplares similares
-
The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023) -
Effect of the 13-valent pneumococcal conjugate vaccine on nasopharyngeal carriage by respiratory pathogens among Greenlandic children
por: Navne, Johan Emdal, et al.
Publicado: (2017) -
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
por: Hammitt, Laura L, et al.
Publicado: (2019) -
Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil
por: Andrade, Ana Lucia, et al.
Publicado: (2014) -
Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
por: Collins, Deirdre A., et al.
Publicado: (2017)